Mgr. Marek Borský
Researcher, Department of Internal Medicine, Hematology and Oncology
Correspondence Address:
Jihlavská 340/20, 625 00 Brno
Phone: | +420 532 23 4830 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 116
2013
-
Mutace v genu TP53 jsou spojeny s vyšší rezistencí CLL buněk na ofatumumab a rituximab in vitro
Year: 2013, type: Conference abstract
-
Normal hematopoietic stem cells can be detected in newly diagnosed chronic myeloid leukemia patients and leukemic stem cells can be detected in CML patients after therapy by a multi-technique approach using antigen CD26.
Year: 2013, type: Conference abstract
-
Surface antigen CD26 as a marker for purification of CML stem cells
Year: 2013, type:
-
The origin of deletion 22q11 in chronic lymphocytic leukemia is related to the rearrangement of immunoglobulin lambda light chain locus
Leukemia Research, year: 2013, volume: 37, edition: 7, DOI
-
The prospective analysis of low level BCR-ABL1 T315I mutation in the CD34+ cells of de novo CML patients
Year: 2013, type: Conference abstract
-
TP53 mutations associate with higher in vitro resistance of CLL cells to ofatumumab and rituximab
Year: 2013, type: Conference abstract
-
TP53 mutations but not ATM mutations associate with higher in vitro resistance of CLL cells to rituximab
Year: 2013, type: Conference abstract
-
Wnt-PCP pathway driving pathogenesis of chronic lymphocytic leukemia participates on normal B-cell development
Year: 2013, type: Conference abstract
2012
-
Analysis of Mutations in the BCR-ABL1 Kinase Domain, Using Direct Sequencing Detection of the T315I Mutation in Bone Marrow CD34+Cells of a Patient with Chronic Myelogenous Leukemia 6 Months Prior to its Emergence in Peripheral Blood
Molecular Diagnosis & Therapy, year: 2012, volume: 16, edition: 3, DOI
-
Exprese nestinu i v nádorových buňkách hematologických malignit - leukémií a lymfomů
Year: 2012, type: Conference abstract